Search

M2 PRESSWIRE-January 7, 2025-: Ocular melanoma Market Expected to rise, 2034 | Bristol Myers Squibb, Merck & Co., Inc., Novartis AG, Roche Holding AG, Pfizer Inc., AstraZeneca PLC, Eli Lilly [...]

T-cell malignancies account for about 10-15% of all lymphoid malignancies, and their treatment often involves chemotherapy, immunotherapy, or stem cell transplantation. These cancers can be particularly challenging due to their [...]

Dublin: Research and Markets has issued the following news release: The 'Sarcoma Drugs - Global Strategic Business Report' report has been added to ResearchAndMarkets.com's offering. The global market for Sarcoma [...]

M2 PRESSWIRE-November 20, 2024-: Multiple Myeloma Market on Track for Major Expansion by 2034, According to DelveInsight | Janssen Pharma, Regeneron Pharma, Johnson & Johnson Innovative Medicine, Bristol Myers Squibb, [...]

M2 PRESSWIRE-November 20, 2024-: Myocardial Infarction Market Expected to Experience Major Growth by 2034, According to DelveInsight | Pfizer, Novartis, AstraZeneca, Recardio, Idorsia Pharma, Eli Lilly and Company, Boehringer (C)1994-2024 [...]

Dublin: Research and Markets has issued the following news release: The 'Alzheimer's Drugs - A Global Market Overview' report has been added to ResearchAndMarkets.com's offering. The global market for Alzheimer's [...]

M2 PRESSWIRE-October 23, 2024-: Axial Spondyloarthritis Market on Track for Major Expansion by 2034, According to DelveInsight | UCB Biopharma, Celgene, Novartis, Pfizer, Merck, Inmagene Biopharma, Galapagos NV, Kyowa Kirin [...]

M2 PRESSWIRE-October 17, 2024-: Global Cancer Therapy Market Size to grow at a CAGR of ~9% by 2030, Evaluates DelveInsight (C)1994-2024 M2 COMMUNICATIONS RDATE:17102024 Cancer Therapy Companies working in the [...]

The rising demand for prostate cancer diagnostics is mainly driven by the growing incidence of the disease, heightened awareness and screening initiatives, and ongoing advancements in diagnostic technologies, projected for [...]

M2 PRESSWIRE-September 24, 2024-: Castrate-resistant Prostate Cancer Market to Show Remarkable Growth Trends from 2023 to 2032, Asserts DelveInsight | Pfizer, Astellas Pharma, Bristol-Myers Squibb, Laekna Therapeutics, Novartis (C)1994-2024 M2 [...]

NEW YORK, Sept. 9, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape- The global autoinjectors market size is estimated to grow by USD 303.65 billion from 2024-2028, [...]

The chemotherapy drugs market is expected to experience significant growth due to several factors, including the rising incidence of various cancers and an increase in risk factors associated with cancer [...]

M2 PRESSWIRE-July 9, 2024-: Axial Spondyloarthritis (axSpA) Market Forecasted to Surge in Coming Years, 2023-2032 Analysis by DelveInsight | UCB Biopharma, Celgene, Novartis, Pfizer, Merck, Inmagene Biopharma, Galapagos NV (C)1994-2024 [...]

M2 PRESSWIRE-June 10, 2024-: Bone Metastasis Market Forecast 2032: FDA, EMA and PDMA Approvals, Epidemiology, Therapies, Companies by DelveInsight | XGEVA (denosumab), XOFIGO (radium-223 dichloride), Cabozantinib, 9-ING-41, more (C)1994-2024 M2 [...]

M2 PRESSWIRE-June 10, 2024-: Acanthamoeba Keratitis Market Forecast 2032: FDA, EMA and PDMA Approvals, Epidemiology, Therapies, Companies by DelveInsight (C)1994-2024 M2 COMMUNICATIONS RDATE:10062024 Acanthamoeba Keratitis companies are Allergan, Merck Sharp [...]

M2 PRESSWIRE-June 3, 2024-: Aromatase Inhibitors Market to Grow at a decent CAGR during the Study Period (2020-2034) by DelveInsight | ANI Pharmaceuticals, Pfizer, Novartis (C)1994-2024 M2 COMMUNICATIONS RDATE:03062024 The [...]

DUBLIN: RESEARCH AND MARKETS has issued the following news release: The 'Global Markets and Technologies for Advanced Drug Delivery Systems' report has been added to ResearchAndMarkets.com's offering. The global market [...]

M2 PRESSWIRE-May 15, 2024-: Chronic Hemodialysis Market to Show a Rise During the Forecast Period | Cara Therapeutics Inc., Bayer, Novartis Pharma, Merck Sharp & Dohme LLC, Pfizer, Medtronic, Abbott, [...]

M2 PRESSWIRE-May 2, 2024-: Sickle Cell Disease Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Vertex Pharma, Agios Pharma, Alexion Pharma, Novartis, Afimmune, Pfizer, ADDMED [...]

M2 PRESSWIRE-April 23, 2024-: Acute Myeloid Leukemia Market Outlook 2032 | Pfizer, Bristol Myers Squibb, Agios Pharmaceuticals, Abbvie, Jazz Pharmaceuticals, Astellas Pharma, Pfizer, Novartis Oncology, Daiichi Sankyo (C)1994-2024 M2 COMMUNICATIONS [...]

M2 PRESSWIRE-April 19, 2024-: Onychomycosis Market to Witness Upsurge in Growth During the Forecast Period (2023-2032), Examine DelveInsight | Merck, Novartis, Novartis, Pfizer, Bayer, Topica Pharma (C)1994-2024 M2 COMMUNICATIONS RDATE:19042024 [...]

M2 PRESSWIRE-April 16, 2024-: Gestational Diabetes Market and Epidemiology 2032: Treatment Therapies, FDA Approvals, Companies and Patient based Forecast by DelveInsight | Antares Pharma, Eli Lilly, Sanofi, Novo Nordisk, Abbott [...]

M2 PRESSWIRE-March 20, 2024-: Autosomal Dominant Polycystic Kidney Disease Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | Pfizer, Otsuka Pharma, [...]

M2 PRESSWIRE-February 22, 2024-: Desmoid Tumors Market to Register Incremental Growth During the Forecast Period (2023-2032), Asserts DelveInsight | Pfizer, Novartis, SpringWorks Therapeutics, Ayala Pharma, Iterion Therapeutics (C)1994-2024 M2 COMMUNICATIONS [...]

M2 PRESSWIRE-February 22, 2024-: Smoking Cessation and Nicotine Addiction Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Pfizer, Inc., Cipla, Novartis, GlaxoSmithKline (C)1994-2024 [...]

Richmond: The Cytomegalovirus (CMV) Treatment Market report focuses on the pharmaceutical and healthcare industries, specifically targeting infections caused by the common herpesvirus virus. The market is expected to grow due [...]

DUBLIN: Research and Markets has issued the following news release: The 'Somatostatin Analogs Market Report: Trends, Forecast and Competitive Analysis to 2030' report has been added to ResearchAndMarkets.com's offering. The [...]

DUBLIN, Feb. 16, 2024 /PRNewswire/ -- The https://www.researchandmarkets.com/report/somatostatin-analogs?utm_source=CI&utm_medium=PressRelease&utm_code=pxlv3l&utm_campaign=1936955+-+Global+Somatostatin+Analogs+Market+Report+2024-2030+Featuring+Major+Players+-+Novartis%2c+Sun+Pharma%2c+Midatech+Pharma%2c+Ipsen+Pharma%2c+Chiasma%2c+Peptron%2c+Dauntless+Pharma%2c+Camurus%2c+Teva%2c+and+Pfizer&utm_exec=chdomspi report has been added toResearchAndMarkets.com's offering. The global somatostatin analogs market is expected to reach an estimated $8.3 billion by 2030 with [...]

M2 PRESSWIRE-February 14, 2024-: Sphingosine 1 Phosphate Receptor (S1PR) Modulators Market to Witness Significant Growth During the Study Period (2019-2032), Assesses DelveInsight | Major Players - Celgene (BMS)), Pfizer, Novartis [...]

NEW YORK, Jan. 17, 2024 /PRNewswire/ -- Thehttps://www.technavio.com/report/antimicrobial-therapeutics-market-size-industry-analysis?utm_source=prnewswire&utm_medium=pressrelease&utm_campaign=T2023_vrd_wk03_2024_021_rep&utm_content=IRTNTR43391 is expected to grow byUSD 51.4 billion from 2022 to 2027. In addition, the momentum of the market will progress at aCAGR [...]

NEW YORK, Jan. 8, 2024 /PRNewswire/ -- The https://www.technavio.com/report/castration-resistant-prostate-cancer-crpc-treatment-market-industry-analysis?utm_source=prnewswire&utm_medium=prnewswire&utm_campaign=T2023_VRD_023wk2_2024_INT1_rep&utm_content=IRTNTR77080 is expected to grow byUSD 5.98 billion from 2023 to 2028. In addition, the momentum of the market will progress at [...]

NEW YORK, Jan. 5, 2024 /PRNewswire/ -- The https://www.technavio.com/report/active-pharmaceutical-ingredients-market-industry-analysis?utm_source=prnewswire&utm_medium=prnewswire&utm_campaign=T2023_VRD_week1_24_TI_019_rep&utm_content=IRTNTR40608 is expected to grow byUSD 86.47 billion from 2023 to 2028. In addition, the momentum of the market will progress at [...]

NEW YORK, Jan. 4, 2024 /PRNewswire/ -- The https://www.technavio.com/report/cancer-immunotherapy-market-industry-analysis?utm_source=prnewswire&utm_medium=prnewswire&utm_campaign=T2023_VRD_week1_24_TI_019_rep&utm_content=IRTNTR71598 is expected to grow byUSD 38.57 billion from 2022 to 2027. In addition, the momentum of the market will progress at [...]

The growth of the metastatic castrate-resistant prostate cancer market is expected to be driven by the expected rising prevalence of prostate cancer cases due to rapidly aging population and growing [...]

DUBLIN, Dec. 19, 2023 /PRNewswire/ -- The https://www.researchandmarkets.com/reports/5876507/global-markets-treatments-syndromes-progressive?utm_source=CI&utm_medium=PressRelease&utm_code=nlds89&utm_campaign=1919986+-+Global+Progressive+Ataxia+and+Weakness+Disorders+Treatment+Market+Report%3a+Focus+on+Key+Players+Novartis%2c+Pfizer%2c+Sanofi%2c+GlaxoSmithKline%2c+Roche%2c+Merck%2c+Takeda+Pharmaceuticals+and+Abbott+Laboratories&utm_exec=cari18prd report has been added toResearchAndMarkets.com's offering. Neurological disorders are surging; this trend is particularly noticeable in syndromes associated with progressive ataxia and [...]

M2 PRESSWIRE-December 14, 2023-: Autosomal Dominant Polycystic Kidney Disease Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Pfizer, Otsuka Pharma, Palladio Biosciences, Novartis (C)1994-2023 M2 [...]

DUBLIN: Research and Markets has issued the following news release: The 'Melanoma Therapeutics: Global Markets' report has been added to ResearchAndMarkets.com's offering. The global market for melanoma treatment was estimated [...]

DUBLIN, Dec. 13, 2023 /PRNewswire/ -- The https://www.researchandmarkets.com/report/melanoma-drug?utm_source=CI&utm_medium=PressRelease&utm_code=f5sgbl&utm_campaign=1917899+-+Global+Melanoma+Treatment+Market+Report+2023%2c+Featuring+Comprehensive+Profiles+of+Leading+Players+including+Amgen%2c+Roche%2c+Merck+%26+Co.%2c+Pfizer+Inc.%2c+BMS+and+Novartis&utm_exec=cari18prd report has been added toResearchAndMarkets.com's offering. The global market for melanoma treatment was estimated to reach $6.8 billion in 2022 and is [...]

NEW YORK, Dec. 12, 2023 /PRNewswire/ -- Thehttps://www.technavio.com/report/report/alzheimers-disease-therapeutics-market-industry-size-analysis?utm_source=prnewswire&utm_medium=prnewswire&utm_campaign=T2023_VRD_wk50_2023_016_rep&utm_content=IRTNTR40742 size is expected to grow byUSD 5.41 billion from 2023 to 2028. In addition, the momentum of the market will progress at [...]

M2 PRESSWIRE-December 11, 2023-: ADPKD Market to Witness Upsurge in Growth During the Forecast Period (2023-2032), Examine DelveInsight | Palladio Biosciences, Kadmon, Novartis, Pfizer, Otsuka Pharma, XORTX Therapeutics, Sanofi (C)1994-2023 [...]

DUBLIN, Dec. 7, 2023 /PRNewswire/ -- The https://www.researchandmarkets.com/reports/5910676/tyrosine-kinase-inhibitors-global-market-outlook?utm_source=CI&utm_medium=PressRelease&utm_code=97ngnl&utm_campaign=1917108+-+Global+Tyrosine+Kinase+Inhibitors+Market+Report+2023-2028%2c+Featuring+Profiles+of+Major+Players+including%c2%a0Astrazeneca%2c+Bayer%2c+Bristol-Myers+Squibb+%2c+Eisai%2c+F.+Hoffmann-La+Roche%2c+Novartis+and+Pfizer&utm_exec=cari18prd report has been added toResearchAndMarkets.com's offering. The report provides an overview of the global tyrosine kinase inhibitor market and analyzes market trends. [...]

M2 PRESSWIRE-December 7, 2023-: Ascites Market Anticipates Steady Growth Throughout the Forecast (2023-2032), Reports DelveInsight | Companies Include AstraZeneca plc, Pfizer Inc., Novartis AG, Baxter, and Roche (C)1994-2023 M2 COMMUNICATIONS [...]

The total metastatic castration-resistant prostate cancer market size in the 7MM was estimated to be nearly USD 2.1 billion in 2022. The market size of the metastatic castration-sensitive prostate cancer [...]